More clarity needed on the true benefits and risks of statins

Aseem Malhotra; John Abramson; Michel De Lorgeril; Sherif Sultan

doi:10.1002/psb.1519

More clarity needed on the true benefits and risks of statins

Aseem Malhotra, John Abramson, Michel De Lorgeril, Sherif Sultan

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

1 Citation (Scopus)

Abstract

The benefits and risks of statins have recently been the subject of much controversy and debate. Dr Malhotra and colleagues argue that selective reporting and publication bias may be overestimating the efficacy and underestimating the side-effects of statins.

Original language	English
Pages (from-to)	15-17
Number of pages	3
Journal	Prescriber
Volume	27
Issue number	12
DOIs	https://doi.org/10.1002/psb.1519
Publication status	Published - 1 Dec 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/psb.1519

Cite this

@article{4b735e061aed46e7b9549783884b0873,

title = "More clarity needed on the true benefits and risks of statins",

abstract = "The benefits and risks of statins have recently been the subject of much controversy and debate. Dr Malhotra and colleagues argue that selective reporting and publication bias may be overestimating the efficacy and underestimating the side-effects of statins.",

author = "Aseem Malhotra and John Abramson and \{De Lorgeril\}, Michel and Sherif Sultan",

note = "Publisher Copyright: Copyright {\textcopyright} 2016 Wiley Interface Ltd",

year = "2016",

month = dec,

day = "1",

doi = "10.1002/psb.1519",

language = "English",

volume = "27",

pages = "15--17",

journal = "Prescriber",

issn = "0959-6682",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "12",

}

TY - JOUR

T1 - More clarity needed on the true benefits and risks of statins

AU - Malhotra, Aseem

AU - Abramson, John

AU - De Lorgeril, Michel

AU - Sultan, Sherif

PY - 2016/12/1

Y1 - 2016/12/1

N2 - The benefits and risks of statins have recently been the subject of much controversy and debate. Dr Malhotra and colleagues argue that selective reporting and publication bias may be overestimating the efficacy and underestimating the side-effects of statins.

AB - The benefits and risks of statins have recently been the subject of much controversy and debate. Dr Malhotra and colleagues argue that selective reporting and publication bias may be overestimating the efficacy and underestimating the side-effects of statins.

UR - https://www.scopus.com/pages/publications/85043623010

U2 - 10.1002/psb.1519

DO - 10.1002/psb.1519

M3 - Article

AN - SCOPUS:85043623010

SN - 0959-6682

VL - 27

SP - 15

EP - 17

JO - Prescriber

JF - Prescriber

IS - 12

ER -

More clarity needed on the true benefits and risks of statins

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this